Mario Gabelli's LFCR Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 83,800 shares of Lifecore Biomedical, Inc. (LFCR) worth $685,484, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in LFCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 13,918 shares. Largest reduction occurred in Q2 2023, reducing 6,500 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Lifecore Biomedical (LFCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lifecore Biomedical (LFCR) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -700 | Reduce 0.83% | 83,800 | $8.18 |
| Q1 2025 | -1,500 | Reduce 1.74% | 84,500 | $7.04 |
| Q4 2024 | -1,500 | Reduce 1.71% | 86,000 | $7.43 |
| Q3 2024 | +6,300 | Add 7.76% | 87,500 | $4.93 |
| Q2 2024 | +5,000 | Add 6.56% | 81,200 | $5.13 |
| Q1 2024 | -300 | Reduce 0.39% | 76,200 | $5.31 |
| Q2 2023 | -6,500 | Reduce 7.83% | 76,500 | $9.67 |
| Q1 2023 | -4,000 | Reduce 4.60% | 83,000 | $3.78 |
| Q4 2022 | +8,000 | Add 10.13% | 87,000 | $6.48 |
| Q3 2022 | +2,000 | Add 2.60% | 79,000 | $8.89 |
| Q2 2022 | +2,000 | Add 2.67% | 77,000 | $9.97 |
| Q1 2022 | +2,000 | Add 2.74% | 75,000 | $11.59 |
| Q4 2021 | +13,918 | Add 23.56% | 73,000 | $11.10 |
| Q3 2021 | +12,582 | Add 27.06% | 59,082 | $9.22 |
| Q2 2021 | +46,500 | New Buy | 46,500 | $11.25 |
Mario Gabelli's Lifecore Biomedical Investment FAQs
Mario Gabelli first purchased Lifecore Biomedical, Inc. (LFCR) in Q2 2021, acquiring 46,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Lifecore Biomedical, Inc. (LFCR) for 19 quarters since Q2 2021.
Mario Gabelli's largest addition to Lifecore Biomedical, Inc. (LFCR) was in Q2 2021, adding 46,500 shares worth $523,000.
According to the latest 13F filing for Q4 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 83,800 shares of Lifecore Biomedical, Inc. (LFCR), valued at approximately $685,484.
As of the Q4 2025 filing, Lifecore Biomedical, Inc. (LFCR) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Lifecore Biomedical, Inc. (LFCR) was 87,500 shares, as reported at the end of Q3 2024.